Federation des caisses Desjardins du Quebec’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.46M Sell
7,549
-1,873
-20% -$611K 0.01% 598
2025
Q1
$2.55M Buy
9,422
+341
+4% +$92.1K 0.01% 541
2024
Q4
$2.13M Sell
9,081
-9,735
-52% -$2.29M 0.01% 564
2024
Q3
$5.17M Buy
18,816
+2,835
+18% +$779K 0.03% 331
2024
Q2
$3.88M Sell
15,981
-704
-4% -$171K 0.02% 377
2024
Q1
$3.17M Buy
16,685
+646
+4% +$123K 0.02% 410
2023
Q4
$3.07M Hold
16,039
0.03% 345
2023
Q3
$2.84M Sell
16,039
-1,167
-7% -$207K 0.03% 349
2023
Q2
$3.27M Sell
17,206
-10,069
-37% -$1.91M 0.03% 351
2023
Q1
$5.46M Sell
27,275
-6,424
-19% -$1.29M 0.06% 231
2022
Q4
$8.01M Hold
33,699
0.09% 174
2022
Q3
$6.75M Sell
33,699
-806
-2% -$161K 0.08% 192
2022
Q2
$5.03M Buy
34,505
+930
+3% +$136K 0.06% 236
2022
Q1
$5.48M Buy
33,575
+1,129
+3% +$184K 0.05% 255
2021
Q4
$5.5M Sell
32,446
-1,569
-5% -$266K 0.05% 247
2021
Q3
$6.42M Sell
34,015
-1,587
-4% -$299K 0.07% 229
2021
Q2
$6.03M Sell
35,602
-745
-2% -$126K 0.06% 246
2021
Q1
$5.13M Sell
36,347
-10,223
-22% -$1.44M 0.06% 258
2020
Q4
$6.06M Sell
46,570
-5,159
-10% -$671K 0.07% 224
2020
Q3
$7.55M Sell
51,729
-4,417
-8% -$645K 0.11% 177
2020
Q2
$8.34M Sell
56,146
-3,311
-6% -$492K 0.13% 156
2020
Q1
$6.55M Hold
59,457
0.11% 141
2019
Q4
$6.84M Buy
59,457
+3,270
+6% +$376K 0.1% 174
2019
Q3
$4.52M Buy
56,187
+25,295
+82% +$2.03M 0.07% 232
2019
Q2
$2.24M Hold
30,892
0.03% 377
2019
Q1
$2.89M Buy
30,892
+7,616
+33% +$712K 0.04% 312
2018
Q4
$1.7M Hold
23,276
0.03% 448
2018
Q3
$2.04M Hold
23,276
0.03% 449
2018
Q2
$2.3M Hold
23,276
0.03% 408
2018
Q1
$2.77M Hold
23,276
0.04% 329
2017
Q4
$2.95M Hold
23,276
0.04% 327
2017
Q3
$2.74M Hold
23,276
0.04% 329
2017
Q2
$1.86M Sell
23,276
-3,536
-13% -$282K 0.03% 458
2017
Q1
$1.37M Buy
+26,812
New +$1.37M 0.03% 486